0000886163-18-000120.txt : 20180817 0000886163-18-000120.hdr.sgml : 20180817 20180817193721 ACCESSION NUMBER: 0000886163-18-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180816 FILED AS OF DATE: 20180817 DATE AS OF CHANGE: 20180817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sunil CENTRAL INDEX KEY: 0001503062 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 181026863 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES RD., SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-08-16 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001503062 Patel Sunil 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2018-08-16 4 M 0 5000 9.6 A 44806 D Common Stock 2018-08-16 4 M 0 7335 10.12 A 52141 D Common Stock 2018-08-16 4 M 0 7335 12.53 A 59476 D Common Stock 2018-08-16 4 M 0 7335 32.3 A 66811 D Common Stock 2018-08-16 4 S 0 42287 240.0456 D 24524 D Non-Qualified Stock Option (right to buy) 9.6 2018-08-16 2018-08-16 4 M 0 5000 0.0 D 2020-10-07 Common Stock 5000 0 D Non-Qualified Stock Option (right to buy) 10.12 2018-08-16 2018-08-16 4 M 0 7335 0.0 D 2021-06-01 Common Stock 7335 0 D Non-Qualified Stock Option (right to buy) 12.53 2018-08-16 2018-08-16 4 M 0 7335 0.0 D 2022-05-31 Common Stock 7335 0 D Non-Qualified Stock Option (right to buy) 32.3 2018-08-16 2018-08-16 4 M 0 7335 0.0 D 2023-06-11 Common Stock 7335 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.31 to $242.68, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option becomes exercisable in 36 successive monthly installments upon completion of each calendar month of service beginning on the grant date. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date. Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date. By: Charles S. Berkman For: Sunil Patel 2018-08-17